CourtneyMichelleCampbellMDPhD

Cardiology • Dallas, TX

Medical Director of Center for Cardio-Oncology at Baylor Heart and Vascular Hospital, Dallas

Join to view full profile

Dr. Campbell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Campbell's full profile

Already have an account?

Office
621 North Hall Street, Suite 500
Dallas, TX 75226
Phone+1 469-800-7400

Summary

Courtney M. Campbell, MD, PhD is a cardiologist at Cardiology Consultants of Texas and the Medical Director of Cardiology-Oncology at Baylor Scott and White Heart and Vascular Hospital, Dallas. She is an expert in the cardiovascular care of oncology patients and in patients with amyloidosis.

Cardio-Oncology includes cardiovascular care prior to cancer therapy, during cancer therapy, and throughout cancer survivorship. The discipline focuses on cardiovascular optimization, cardiac monitoring, and preventive cardiovascular care throughout the cancer spectrum. In addition, cardio-oncology aims to minimize disruption in cancer therapy through management of short- and long-term cancer-treated related cardiotoxicity and treatment of acute cardiac issues. Cardio-Oncology is a highly dynamic field as cancer and amyloidosis therapy rapidly evolves.

Within the Cardiology-Oncology program, we seek to bring the latest advances and approaches to our patients to improve their quality of life via excellent patient care, engagement in clinical trials, and robust clinical-translational research collaborations. As a physician-scientist, Dr. Campbell's research interests are in early diagnostic approaches and intervention in cardio-oncology and amyloidosis through prospective studies, clinical trials, and multidisciplinary collaboration.

Dr. Campbell was born and raised in Dallas, Texas. She studied History of Science at Harvard University, completing bachelor’s and master’s degrees. She earned her MD and PhD in Pharmacology from Vanderbilt University. As part of the Physician Scientist Training Program, she completed her internal medicine residency and cardiovascular medicine fellowship at The Ohio State University. She then completed additional fellowship training in Cardio-Oncology and Amyloidosis at Washington University in St. Louis and served as an attending (supervising) physician. She is thrilled to be home now in Dallas, serving the community she grew up in.

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Cardio-Oncology and Amyloidosis, 2021 - 2022
Ohio State University HospitalFellowship, Cardiovascular Disease, 2017 - 2021
Ohio State University HospitalResidency, Internal Medicine, 2015 - 2017
Vanderbilt University School of MedicineClass of 2015
Vanderbilt University Graduate SchoolPhD, Pharmacology, 2007 - 2013
Harvard UniversityMA, History of Science, 2005 - 2006
Harvard UniversityBA, History of Science, Cum Laude, 2002 - 2006

Certifications & Licensure

TX State Medical License 2022 - 2026
MO State Medical License 2021 - 2025
OH State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
International Cardio-Oncology Society Board Certification in Cardio-Oncology

Publications & Presentations

PubMed

1 citations
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement.
Richard Cheng, Michelle M Kittleson, Ashutosh D Wechalekar, Jose Alvarez-Cardona, Joshua D Mitchell
Heart. 2024-05-23
2 citations
Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021.
Sherry-Ann Brown, Craig Beavers, Brenton Bauer, Richard K Cheng, Generika Berman
American Heart Journal Plus. 2024-02-01
4 citations
Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review.
Emre Aldinc, Courtney Campbell, Finn Gustafsson, Abigail Beveridge, Richard Macey
BMC Musculoskeletal Disorders. 2023-09-22

Abstracts/Posters

Initiation of Cardiology Care in Cardiac Amyloidosis: A Single Center Experience
Campbell CM, Mbeng CA, Rodgers B, Bumma N, Efebera Y, Sharma N, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Kahwash R, Vallakati A, International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
Orthopaedics History Preceding Diagnosis of Cardiac Amyloidosis: Timing and Variation by Subtype
Campbell CM, Mbeng CA, Rodgers B, Bumma N, Efebera Y, Sharma N, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Redder E, Kahwash R, Vallaka..., International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
High price and US insurance practices delay and limit access to Tafamidis for patients with transthyretin cardiac amyloidosis: A Single Center Experience.
Campbell CM, Bumma N, Efebera Y, Sharma N, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Redder E, Kahwash R, Vallkati A, International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
Favorable outcomes with autologous stem cell transplant in AL amyloidosis patients with extensive organ involvement
Bumma N, Sharma N, Campbell CM, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Redder E, Kahwash R, Vallakati A, Efebera Y., International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
Renal outcomes in patients with AL amyloidosis undergoing autologous stem cell transplant who have achieved CR/VGPR
Bumma N, Efebera Y, Sharma N, Campbell CM, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Redder E, Kahwash R, Vallakati A, Efebera Y, International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
Feasibility of the combination of Tafamidis and mRNA interfering therapy in patients with transthyretin (ATTR) amyloidosis
Bumma N, Efebera Y, Sharma N, Campbell CM, Parikh S, Almaani S, Prosek J, Bittengler J, Pfund K, Freimer M, Redder E, Kahwash R, Vallakati A, LoRusso S, International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
Development of a New Hybrid Staging System for AL amyloidosis: Incorporating BNP, Troponin, and dFLC in Patients with AL amyloidosis
Ozga M, Zhao Q, Benson D, Elder P, Williams N, Bumma N, Rosko A, Chaudhry M, Khan A, Devarakona S, Kahwash R, Vallkati A, Campbell CM, Parikh S, Almaani S, Prosek J, R..., International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
AL Amyloidosis: Maintenance Therapy following Autologous Stem Cell Transplant (ASCT)
Ozga M, Zhao Q, Benson D, Elder P, Williams N, Rosko A, Chaudry M, Khan A, Devarakona S, Kahwash R, Vallakati A, Campbell CM, Parikh S, Almaani S, Prosek J, Redder E, ..., International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
AL Amyloidosis: The Prognostic Impact of Cytogenetic Abnormalities on Organ Involvement and Survival.
Ozga M, Zhao Q, Benson D, Elder P, Williams N, Bumma N, Rosko A, Chaudhry M, Khan A, Devarakona S, Kahwash R, Vallakati A, Campbell CM, Parikh S, Almaani S, Prosek J, ..., International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
Functional Limitations of Patients with TTR Amyloidosis
Redder E, Bittengle J, Pfund K, LoRusso S, Freimer M, Campbell CM, Kahwash R, Vallakati A, Bumma N, Parikh S, Almaani S, Sharma N, Bumma N, Efebera Y, International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
Distinct Electrocardiogram Findings of Cardiac Amyloidosis by Major Amyloid Type
Vedachalam S, Braga JR, Mbeng CA, Rodgers B, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Redder E, Bumma N, Efebera Y, Kahwash R, Vallak..., Heart Rhythm Society Scientific Sessions, San Diego, CA, 5/2020
Rehabilitation of the Amyloidosis Patient
Redder E, Bittengle J, Pfund K, Campbell CM, Bumma N, Sharma N, Parikh S, Almaani S, Prosek J, LoRusso S, Freimer M, Kahwash R, Vallakati A, and Efebera Y, National Comprehensive Cancer Network Annual Conference, Orlando, FL, 3/2020
Memantine Is Associated with Decreased Hospital Admission for Heart Failure Exacerbation, But Not Arrhythmia
Huang AW, Janssen PML, Kahwash R, and Campbell CM, American College of Cardiology Scientific Session, Chicago, IL, 3/2020
The Yield of Transthoracic and Tranesophageal Echocardiograms in Ischemic Stroke Work-up
Foreman B, Campbell CM, Carter R, Sosh DL, Orsinelli DA, and Lee VH, American College of Cardiology Scientific Session, Chicago, IL, 3/2020
False Atrial Fibrillation Alerts from Implantable Loop Recorders in Patients with Embolic Stroke of Undetermined Source
Campbell CM, Foreman B, Sosh DL, Carter R, Lee VH, and Orsinelli DA, American College of Cardiology Scientific Session, Chicago, IL, 3/2020
Timing and Yield of Long-term Cardiac Rhythm Monitoring for Atrial Fibrillation Detection in Embolic Stroke of Undetermined Source
Campbell CM, Foreman B, Sosh DL, Carter R, Lee VH, and Orsinelli DA, American College of Cardiology Scientific Session, Chicago, IL, 3/2020
Etiology-dependent changes of force and kinetics in left ventricular end-stage failing human myocardium
Mashali M, Saad, NS, Canan BD, Elnakish MT, Chung JH, Kiduko SA, Peczkowski KK, Huang AW, Fazlollahi F, Hare A, Campbell CM, Mohler PJ, Kilic A, Whitson B, and Janssen..., Biophysical Society, San Diego, CA, 2/2020
Delays in Diagnosis of Transthyretin Cardiac Amyloidosis after Establishing Cardiac Care
Campbell CM, Mbeng CA, Rodgers B, Bumma N, Efebera Y, Sharma N, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Redder E, Kahwash R, and Val..., Advancing the Cardiovascular Care of the Oncology Patient, American College of Cardiology (ACC), Washington, DC, 2/2020
Hare A, Peczkowski KK, Fazlollahi F, Mashali M, Huang AW, Kiduko SA, Saad NS, Elnakish MT, Campbell CM, and Janssen PML
Positive Inotropic Response to (-)-Epigallocatechin-3-Gallate in Isolated Human Myocardium, Biophysical Society, San Diego, CA, 2/2020
Campbell CM, Bumma N, Sharma N, LoRusso S, Redder E, Almaani S, Prosek J, Freimer M, Pfund K, Speiser M, Bittengle J, Dempsey J, Stino A, Kahwash R, Efebera Y, Parikh ...
Untangling a Complex Web: Implementation of a Multidisciplinary Comprehensive Amyloidosis Clinic, Advancing the Cardiovascular Care of the Oncology Patient, American College of Cardiology (ACC), Washington, DC, 2/2020
The Effect of Cytogenetic Abnormalities on Organ Involvement and Survival in Patients with AL Amyloidosis
Courtney Campbell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
AL Amyloidosis: The Effects of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes
Courtney Campbell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
AL Amyloidosis: The Effects of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes
Ozga M, Zhao Q, Benson D, Elder P, Williams N, Bumma N, Rosko A, Chaudhry M, Khan A, Devarakonda S, Kahwash R, Vallkati A, Campbell CM, Parikh S, Almaani S, Prosek J, ..., Annual Meeting, American Society of Hematology (ASH), Orlando, FL, 12/2019
The Effect of Cytogenetic Abnormalities on Organ Involvement and Survival in Patients with AL Amyloidosis
Ozga M, Zhao Q, Benson D, Elder P, Williams N, Bumma N, Rosko A, Chaudhry M, Khan A, Devarakonda S, Kahwash R, Vallkati A, Campbell CM, Parikh S, Almaani S, Prosek J, ..., Annual Meeting, American Society of Hematology (ASH), Orlando, FL, 12/2019
Atypical Hemolytic Uremic Syndrome: A Case Report of a Rare Cause of Reversible Cardiomyopathy
Campbell CM, Cassol C, Cataland SR, and Kahwash R, American College of Cardiology, Ohio Chapter, Annual Meeting, Columbus, OH, 10/2019
Join now to see all

Press Mentions

Long Delays in Amyloidosis Dx, Even With Established Cardiac CareJune 30th, 2020
ACC Cardio-Oncology Course Drives Discourse, Innovation in Fast-Growing FieldOctober 16th, 2020